These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26305347)

  • 1. [SentiMag--the magnetic detection system of sentinel lymph nodes in breast cancer].
    Coufal O; Fait V; Lžičařová E; Chrenko V; Žaloudík J
    Rozhl Chir; 2015 Jul; 94(7):283-8. PubMed ID: 26305347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope.
    Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
    Breast; 2014 Apr; 23(2):175-9. PubMed ID: 24484967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: A comparative non-inferiority study.
    Piñero-Madrona A; Torró-Richart JA; de León-Carrillo JM; de Castro-Parga G; Navarro-Cecilia J; Domínguez-Cunchillos F; Román-Santamaría JM; Fuster-Diana C; Pardo-García R;
    Eur J Surg Oncol; 2015 Aug; 41(8):991-7. PubMed ID: 25997792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study).
    Vidya R; Khosla M; Laws S; Harvey J; Kaushik M; Mullapudi NA; Macmillan D
    Surgeon; 2023 Apr; 21(2):128-134. PubMed ID: 35551871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment.
    Ghilli M; Carretta E; Di Filippo F; Battaglia C; Fustaino L; Galanou I; Di Filippo S; Rucci P; Fantini MP; Roncella M
    Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 26365441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial.
    Houpeau JL; Chauvet MP; Guillemin F; Bendavid-Athias C; Charitansky H; Kramar A; Giard S
    J Surg Oncol; 2016 Apr; 113(5):501-7. PubMed ID: 26754343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
    Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
    Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Sentimag system for guiding sentinel node biopsies in patients with breast cancer.
    Abidi H; Bold RJ
    Expert Rev Med Devices; 2024; 21(1-2):1-9. PubMed ID: 37992402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.
    Teshome M; Wei C; Hunt KK; Thompson A; Rodriguez K; Mittendorf EA
    Ann Surg Oncol; 2016 May; 23(5):1508-14. PubMed ID: 26893221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial.
    Douek M; Klaase J; Monypenny I; Kothari A; Zechmeister K; Brown D; Wyld L; Drew P; Garmo H; Agbaje O; Pankhurst Q; Anninga B; Grootendorst M; Ten Haken B; Hall-Craggs MA; Purushotham A; Pinder S;
    Ann Surg Oncol; 2014 Apr; 21(4):1237-45. PubMed ID: 24322530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing SentiMag in a rural setting: a 5-year experience.
    Sreedhar S; Maloney J; Hudson S
    ANZ J Surg; 2021 Nov; 91(11):2404-2410. PubMed ID: 34309147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Turkish SentiMAG feasibility trial: preliminary results.
    Vural V; Yılmaz OC
    Breast Cancer; 2020 Mar; 27(2):261-265. PubMed ID: 31621053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
    Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentimag® Technique for Sentinel Lymph Node Biopsy in Breast Cancer Patients: Evaluation of Effectiveness, Feasibility and Challenges.
    Nadeem M; Ansari B; Osborne C
    Chirurgia (Bucur); 2022 Feb; 117(1):37-44. PubMed ID: 35272753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers.
    Krischer B; Forte S; Niemann T; Kubik-Huch RA; Leo C
    Eur J Surg Oncol; 2018 Jan; 44(1):74-79. PubMed ID: 29217399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to the article by Thill et al.: "The Central-European SentiMag study: sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014.
    Barranger E; Ihrai T
    Breast; 2014 Jun; 23(3):297. PubMed ID: 24721742
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Barranger E, Ihrai T, response to the article by Thill et al.: "The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope". The Breast 2014, 23(2):175-9.
    Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
    Breast; 2014 Oct; 23(5):692. PubMed ID: 25067809
    [No Abstract]   [Full Text] [Related]  

  • 18. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
    Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
    J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study.
    Follacchio GA; Monteleone F; Anibaldi P; De Vincentis G; Iacobelli S; Merola R; D'Orazi V; Monti M; Pasta V
    J Exp Clin Cancer Res; 2015 Oct; 34():113. PubMed ID: 26445493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of fluorescence with a magnetic tracer and dilution effect upon sentinel node localization in a murine model.
    Kuwahata A; Ahmed M; Saeki K; Chikaki S; Kaneko M; Qiu W; Xin Z; Yamaguchi S; Kaneko A; Douek M; Kusakabe M; Sekino M
    Int J Nanomedicine; 2018; 13():2427-2433. PubMed ID: 29719391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.